Immunogenicity of tumor peptides: Importance of peptide length and stability of peptide/MHC class II complex

Cancer Immunology Immunotherapy

Volumn 48, Issue 4, 1999, Pages 195-203

  Grohmann, Ursula ^a   Belladonna, Maria Laura ^a   Bianchi, Roberta ^a   Orabona, Ciriana ^a   Silla, Silvia ^a   Squillacioti, Giuseppe ^a   Fioretti, Maria Cristina ^a   Puccetti, Paolo ^a  

^a UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Dendritic cells; Immunogenicity; MHC class II; SDS stability; Tumor peptide

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN RECOGNITION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; HELPER CELL; IMMUNOGENICITY; IMMUNOREACTIVITY; LYMPHOCYTE ACTIVATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN STABILITY;

AMINO ACID SEQUENCE; ANIMALS; HISTOCOMPATIBILITY ANTIGENS CLASS II; HYPERSENSITIVITY, DELAYED; IMMUNIZATION; INTERFERON TYPE II; INTERLEUKIN-12; MALE; MICE; MICE, INBRED DBA; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0032864871     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620050565     Document Type: Article

References (21)

1. 1. Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P (1996) IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells. J Immunol 157:1589
2. 2. Boon T, Bruggen P van der (1996) Human tumor antigens recognized by T lymphocytes. J Exp Med 183:725
3. 7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 156:450
4. 4. Germain RN, Hendrix LR (1991) MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134
5. - or helper peptides in priming for skin test reactivity to a P815AB-related peptide. Eur J Immunol 25:2797
6. 6. Grohmann U, Bianchi R, Ayroldi E, Belladonna ML, Surace D, Fioretti MC, Puccetti P (1997) A tumor-associated and self antigen peptide presented by dendritic cells may induce T cell anergy in vivo, but IL-12 can prevent or revert the anergic state. J Immunol 158:3593
7. 7. Grohmann U, Bianchi R, Belladonna ML, Silla S, Surace D, Fioretti MC, Puccetti P (1997) Dendritic cells and interleukin 12 as adjuvants for tumor-specific vaccines. Adv Exp Med Biol 417:579
8. 8. Grohmann U, Belladonna ML, Bianchi R, Orabona C, Ayroldi E, Fioretti MC, Puccetti P (1998) IL-12 acts directly on DC to promote nuclear localization of NF-κB and primes DC for IL-12 production. Immunity 9:315
9. + lymphocytes in the initiation of class I-restricted reactivity to a tumor/self peptide. Crit Rev Immunol 18:87
10. 10. Lethé B, Van den Eynde B, Van Pel A, Corradin G, Boon T (1992) Mouse tumor rejection antigens P815 A and P815B: two epitopes carried by a single peptide. Eur J Immunol 22:2283
11. 11. Nabavi N, Ghogawala Z, Myer A, Griffith IJ, Wade NF, Chen ZZ, McKean DJ, Glimcher LH (1989) Antigen presentation abrogated in cells expressing truncated Ia molecules. J Immunol 142:1444
12. 12. Nelson CA, Petzold SJ, Unanue ER (1993) Identification of two distinct properties of class II major histocompatibility complex-associated peptides. Proc Natl Acad Sci USA 90:1227
13. + T cell responses in antitumor immunity. Curr Opin Immunol 10:588
14. + T cell reactivity. Eur J Immunol 24:1446
15. 15. Rammensee HG (1995) Chemistry of peptides associated with MHC class I and class II molecules. Curr Opin Immunol 7:85
16. 16. Rothbard JB, Gefter ML (1991) Interactions between immunogenic peptides and MHC proteins. Annu Rev Immunol 9:527
17. 17. Sette A, Southwood S, O'Sullivan D, Gaeta FCA, Sidney J, Grey HM (1992) Effect of pH on MHC class II-peptide interactions. J Immunol 148:844
18. 18. Van den Eynde B, Lethé B, Van Pel A, De Plaen E, Boon T (1991) The gene coding for a major tumor rejection antigen of tumor P815 is identical to the normal gene of syngeneic DBA/2 mice. J Exp Med 173:1373
19. d and is recognized by cytotoxic T lymphocytes against mouse tumor P815. Eur J Immunol 24:2740
20. 20. Verreck FA, Vermeulen C, Poel AV, Jorritsma P, Amons R, Coligan JE, Drijifhout JW, Koning F (1996) The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding. Int Immunol 8:397
21. 21. Wu S, Gorski J, Eckels DD, Newton-Nash DK (1996) T cell recognition of MHC class II-associated peptides is independent of peptide affinity for MHC and sodium dodecyl sulfate stability of the peptide/MHC complex. J Immunol 156:3815